Mervat Nasry Wahba is a Neurologist in Memphis, Tennessee and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital-Memphis and Methodist Hospitals of Memphis. She has completed her Medical degree at Cairo University School of Medicine and has been in practice for more than 20 years. She is one of the 62 doctors at Baptist Memorial Hospital-Memphis and one of 52 doctors at Methodist Hospitals of Memphis who specialize in Neurology.
Zhou Wu, PhD., is chair of department of Aging Science and Pharmacology, Faculty of Dental Science at the Kyushu University at Fukuoka, Japan. She graduated from medical college of Jilin University and worked as a clinic doctor for 10 years in China. She received her PhD from Kyushu University in 2001 and received postdoctoral fellow of Japan Society for the Promotion of Science (2002-2004) in Japan. After worked as an assistant professor in the Laboratory of Oral Aging Science (2004-2009), she promoted to associate professor in the Department of Aging Science and Pharmacology at the Kyushu University from 2010. Dr. Wuâ€™s research is primarily focused on how systemic inflammation affects the onset and pathological process of Alzheimerâ€™s disease at molecular and cellular levels. Dr. Wu's works is particularly interested in the functions of Cathepsins, the lysosomal enzymes, in innate and adaptive immunity, in particular how Cathepsins mediate pro-inflammatory molecule productions to amplify inflammation as well as in Aging andï€ Alzheimerâ€™s disease. It is to be noted that Dr. Wuâ€™s current works of clarifying the involvement of cathepsins in P. gingivalis- related periodontitis in onset and pathological process of Alzheimerâ€™s disease. Dr. Wuâ€™ s research is also interest in regulation of oxidative stress-related neuroinflammation, as well as systemic inflammation by nature production, which connect to innovate the early intervention approaches for prevention and clinic management of Alzheimerâ€™s disease.
Haruo Nakayama is an Associate Professor at Department of Neurosurgery, Toho University School of Medicine and working as a neurosurgeon at Toho University Ohashi Medical Center. He did his B.A and Ph.D in Medicine from Toho University in 2003 and 2010 respectively. His research interest includes neurotraumatology, neuromodulation, neurointensive care, sports related head injury and CNS infection.
Haruo Nakayama(Research Area)
neurotraumatology, neuromodulation, neurointensive care, sports related head injury and CNS infection.
Puja Kapoor is a Consultant Paediatric Neurologist at Paras Hospital, Gurgaon. She is M.D and co-founder of CONTINUA Kids in 2016. She worked as Consultant Paediatric Neurologist at Artemis Hospital, Gurgaon from 2013 to 2016. She got her M.B.B.S degree from Himalayan Institute of Medical Sciences, Uttarakhand. She got Diplomate degree in Paediatrics from Choitram Hospital and Research Centre, M. P. She got her fellowship from Case Western University, Cleveland, Ohio U.S.A. She enhanced her knowledge on imaging studies by discussing MRI, CT, PET scans and also attended neuroradiology meets periodically. She has interest in Neuroradiology, Paediatric Neurology, Neurosurgery, and Electrophysiology.
Patrick E. Vigren is Consultant Neurosurgeon and Head of Neurology Department, Linkoping University Hospital. He did his MD From Karolinska Institute and PhD from Linkoping University in 2004 and 2017 respectively. He is Chairman of Regional Stroke Council and Regional Board of Neural Disorders from 2015 and 2012 respectively. He is President and Founder of Student Body of Swedish Society of Medicine. He got Honorary President award for his contribution towards Student Body of Swedish Society of Medicine. His research areas are focused in field of Neurology, Neurosurgery and Stroke.
Dr. K. P. Singh is currently working as a professor in the Department of Zoology, University of Allahabad, Allahabad, INDIA. He started his research on Developmental Neurotoxicity of CNS Acting Drugs covering the broad area of neuropsycopharmacology including neuroanatomy, pharmacology, neurochemistry and neurobehaviour in rodent (Rat/Mice) model. At present, his neurobiology laboratory is involved to investigate the effect of novel pschycotropic (Antiepileptic, Antipsychotic, Antidepressant) drug exposure during pregnancy and lactation on fetal/neonatal birth defects, neuropathological alterations in different regions of fetal brain viz, Cerebral cortex, Caudate putamen, Hippocampus and Cerebellum etc., neurodevelopmental delay in offspring as well as longâ€“lasting impact on neurobehavioural impairment in young-adult offspring. This laboratory is also engaged to find out the involved interactive mechanisms through neurotransmitters, nerve growth factors, apoptotic neurodegeneration, pro-apoptotic (Bax) and anti-apoptotic (Bcl2) protein expression, glial-neuronal cell interactions and genotoxicity of drugs.
Dr Jay Seitz is a neuropsychologist, health consultant, entrepreneur, writer, arts supporter, and canine and nature aficionado (hiking, mountain/trail biking, and off-roading). Formerly, he was a practicing neuropsychologist but is currently launching a healthcare startup. Neurocognitive Therapeutics, LLC is a healthcare startup specializing in helping everyday consumers leverage developments in phytonutrients and nutraceuticals to enhance cognition and higher-order cognitive abilities for healthy aging as well as general well-being of body and mind. He just finished a book in evolutionary cognitive neuroscience on the evolutionary origins of complex cognitive abilities in modern humans as well as an article on neuroaesthetics.
Feng Zheng, graduating as Doctor of Medicine from Medical School of University of Cologne, Germany and now working as Associate Professor at Dept. of Neurosurgery, First Affiliated Hospital of Gannan Medical University, China, has his expertise in neuro-oncology and cerebrovascular disease. In the medical centre, there are more than 250 patients with neural tumors receiving micro-surgeries and endoscopic surgeries, and over 300 patients with cerebrovascular disease receiving endovascular treatment and micro-surgeries per year, which allows contributions of clinical research to Neuroscience. The author looks forward to cooperation with international colleagues.